Gail Adler is an Endocrinology/Metabolic physician affiliated with Brigham and Women's Hospital. OpenAlex indexes 241 publications with 9,934 citations (h-index 52); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
221 Longwood Ave
R F B 2
Boston, MA 021155804
Telephone
617-732-5661Registry record last updated 13 Jul 2012.
Clinical trials
- Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension
Sponsor: Brigham and Women's Hospital
- The Functional Neuroanatomy of the Human Physiological Stress Response
Sponsor: Brigham and Women's Hospital
- Hypoglycemia and Autonomic Nervous System Function-B
Sponsor: Brigham and Women's Hospital
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
39.8%Aldosterone antagonist (MRA)30.1%Spironolactone62%Eplerenone38%Part D<11 patientsThiazide diuretic9.8%Hydrochlorothiazide100%Part D<11 patientsSensory organs
32.5%Corticosteroid32.5%Hydrocortisone100%Part D<11 patientsHormonal (systemic)
27.6%l-Thyroxine18.7%Levothyroxine Sodium100%Part D<11 patientsMineralocorticoids8.9%Fludrocortisone Acetate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
13 NIH research awards on record, funded 1988–2026 per NIH RePORTER. The latest:
- Mineralocorticoid receptor, coronary microvascular function, and cardiac efficiency in hypertension
Brigham and Women'S Hospital
FY2026$759,113R01HL162960 - Training Program in Patient-Oriented Research in Cardiovascular Endocrinology
Brigham and Women'S Hospital
FY2026$406,384T32HL176440 - Mineralocorticoid receptor, coronary microvascular function, and cardiac efficiency in hypertension
Brigham and Women'S Hospital
FY2025$775,984R01HL162960
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital
Marc Sabatine, MD
Brigham and Women's Hospital
Yousef Saleh Khader
Jordan University of Science and Technology
Jens Juul Holst
University of Copenhagen
Victor Montori, MD
Mayo Clinic
Christos Mantzoros, MD
Harvard Medical School
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”